April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Mohamad Mohty shares long-term survival outcomes from the phase II MagnetisMM-3 study – Multiple Myeloma Hub
Jun 20, 2024, 11:53

Mohamad Mohty shares long-term survival outcomes from the phase II MagnetisMM-3 study – Multiple Myeloma Hub

Multiple Myeloma Hub shared on X/Twitter:

CONGRESS | POSTER | EHA2024 | Mohamad Mohty shares long-term survival outcomes from the phase II MagnetisMM-3 study of elranatamab in patients with RRMM, N=123. ORR remained at 61%, with median DoR not reached.”

Mohamad Mohty shares long-term survival outcomes from the phase II MagnetisMM-3 study - Multiple Myeloma Hub

Source: Multiple Myeloma Hub/X